Health
AHA: Risk-Benefit of Mitral Valve Surgery Plus Tricuspid Annuloplasty Studied – HealthDay News
For mitral valve surgery plus TA, risk for primary end-point event lower at two years, but risk for permanent pacemaker implantation…
FRIDAY, Nov. 19, 2021 (HealthDay News) — For patients undergoing surgery for degenerative mitral regurgitation who have moderate or less-than-moderate tricuspid regurgitation, those who also undergo tricuspid annuloplasty (TA) are less likely to have progression…
Continue Reading
